Compugen Ltd. Share Price Deutsche Boerse AG
Stocks
CW9
IL0010852080
Biotechnology & Medical Research
| Market Cap | 216M 188M 173M 161M 306M 20.53B 311M 2.08B 807M 10.07B 810M 792M 34.7B | P/E 2026 * |
-7.86x | P/E 2027 * | -7.97x |
|---|---|---|---|---|---|
| Enterprise Value | 216M 188M 173M 161M 306M 20.53B 311M 2.08B 807M 10.07B 810M 792M 34.7B | EV / Sales 2026 * |
22.9x | EV / Sales 2027 * | 13.4x |
| Free-Float |
97.92% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Compugen Ltd.
| 1 day | -2.88% |
| Manager | Title | Age | Since |
|---|---|---|---|
Eran Ophir
CEO | Chief Executive Officer | - | 22/09/2025 |
David Silberman
DFI | Director of Finance/CFO | 42 | 14/08/2024 |
Pierre Ferre
COO | Chief Operating Officer | 49 | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Anat Cohen-Dayag
CHM | Chairman | 59 | 22/09/2025 |
Gilead Halevy
BRD | Director/Board Member | 59 | 10/06/2018 |
Sanford Zweifach
BRD | Director/Board Member | 70 | 10/06/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.88% | -9.82% | - | - | 201M | |
| +0.36% | +5.10% | +1.04% | +5.85% | 48.62B | |
| +0.92% | +6.21% | +408.85% | +607.44% | 39.86B | |
| +1.89% | +11.06% | +25.75% | -7.89% | 33.91B | |
| +2.38% | +8.10% | +21.83% | +66.94% | 32.32B | |
| +1.20% | +2.02% | +9.79% | +32.43% | 24.73B | |
| +2.51% | +4.94% | - | - | 16.63B | |
| +2.58% | +7.24% | +71.03% | +132.17% | 15.52B | |
| +0.99% | +1.26% | +13.98% | +18.88% | 13.63B | |
| -1.14% | +7.52% | +14.75% | -30.83% | 13.41B | |
| Average | +0.88% | +6.58% | +70.87% | +103.12% | 26.52B | |
| Weighted average by Cap. | +1.27% | +7.00% | +88.55% | +131.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.41M 8.23M 7.55M 7.04M 13.35M 896M 13.58M 90.95M 35.25M 440M 35.35M 34.58M 1.51B | 16.05M 14.02M 12.88M 12.01M 22.77M 1.53B 23.15M 155M 60.09M 749M 60.26M 58.95M 2.58B |
| Net income | -27.6M -24.11M -22.14M -20.65M -39.15M -2.63B -39.81M -267M -103M -1.29B -104M -101M -4.44B | -28.01M -24.48M -22.48M -20.96M -39.74M -2.67B -40.41M -271M -105M -1.31B -105M -103M -4.51B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
